The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Sentry Investment Management LLC

Sentry Investment Management LLC reduced its position in The Cooper Companies, Inc. (NASDAQ:COO) by 14.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 740 shares of the medical device company’s stock after selling 120 shares during the period. Sentry Investment Management LLC’s holdings in Cooper Companies were worth $68,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allworth Financial LP grew its stake in Cooper Companies by 45.8% in the third quarter. Allworth Financial LP now owns 968 shares of the medical device company’s stock worth $107,000 after purchasing an additional 304 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Cooper Companies by 25.0% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,833 shares of the medical device company’s stock worth $1,958,000 after acquiring an additional 3,566 shares during the period. Arkadios Wealth Advisors acquired a new position in shares of Cooper Companies during the third quarter worth approximately $277,000. Wealth Enhancement Advisory Services LLC boosted its position in Cooper Companies by 33.3% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 9,061 shares of the medical device company’s stock worth $1,000,000 after acquiring an additional 2,264 shares during the period. Finally, State of Alaska Department of Revenue grew its position in Cooper Companies by 1.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 24,142 shares of the medical device company’s stock valued at $2,663,000 after buying an additional 355 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on COO shares. Morgan Stanley lowered their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup dropped their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Finally, StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Trading Down 1.2 %

Cooper Companies stock opened at $89.87 on Friday. The company has a 50 day moving average price of $92.71 and a 200 day moving average price of $99.49. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The firm has a market capitalization of $17.94 billion, a price-to-earnings ratio of 46.09, a P/E/G ratio of 2.25 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 earnings per share. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.